Cargando…
Personalized Management of Dry Eye Disease: Beyond Artificial Tears
Dry eye disease (DED) is a multifactorial disease of the ocular surface that may be accompanied by discomfort and visual disturbances to a level that reduces quality of life. Artificial tears are a common first-line therapy for DED that aim to supplement the tear film but do not address the underlyi...
Autores principales: | Matossian, Cynthia, Crowley, Micaela, Periman, Laura, Sorkin, Steven |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9704006/ https://www.ncbi.nlm.nih.gov/pubmed/36452043 http://dx.doi.org/10.2147/OPTH.S384819 |
Ejemplares similares
-
Artificial Tears: Biological Role of Their Ingredients in the Management of Dry Eye Disease
por: Labetoulle, Marc, et al.
Publicado: (2022) -
Dry eye: why artificial tears are not always the answer
por: Kim, Minji, et al.
Publicado: (2021) -
A Review of the Mechanism of Action of Cyclosporine A: The Role of Cyclosporine A in Dry Eye Disease and Recent Formulation Developments
por: Periman, Laura M, et al.
Publicado: (2020) -
The Immunological Basis of Dry Eye Disease and Current Topical Treatment Options
por: Periman, Laura M., et al.
Publicado: (2020) -
Characterization of the serological biomarkers associated with Sjögren’s syndrome in patients with recalcitrant dry eye disease
por: Matossian, Cynthia, et al.
Publicado: (2016)